<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04891822</url>
  </required_header>
  <id_info>
    <org_study_id>SNU-SLEEVE</org_study_id>
    <nct_id>NCT04891822</nct_id>
  </id_info>
  <brief_title>ERAS After Bariatric Surgery in Morbidly Obese</brief_title>
  <official_title>Enhanced Recovery After Bariatric Surgery(ERAS) in the Morbidly Obese Using Evidence-Based Clinical Pathways: A Prospective Observational Non-randomized Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, the number of bariatric surgery is increasing but ERAS (Enhanced Recovery After&#xD;
      Surgery) protocol for bariatric surgery needs revision with evidence. So we investigated&#xD;
      usefulness of ERAS protocol for bariatric surgery in morbidly obese patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing elective laparoscopic bariatric surgery are going to be recruited and&#xD;
      divided into 2 groups: Group E will receive ERAS protocol, and Group C will receive standard&#xD;
      perioperative care.&#xD;
&#xD;
      ERAS protocol comprises 8 hours of fasting and ingestion of oral carbohydrate 2 hour before&#xD;
      surgery, TIVA(Total intra-venous anesthesia), TAP(transversus abdominis plane) block and&#xD;
      IV-PCA using NSAIDs after surgery, and resumption of oral intake 2 hour after surgery.&#xD;
&#xD;
      Conventional anesthesia is composed of 8 hours of fasting, inhalation anesthesia, IV-PCA&#xD;
      using NSAIDs, and resumption oral intake 6 hour after surgery.&#xD;
&#xD;
      In both groups, gastric ultrasonography will be used to measure gastric volume before&#xD;
      surgery.&#xD;
&#xD;
      Functional hospital stay will be recorded from the end of surgery until all discharge&#xD;
      criteria had been met. Pain scores will be recorded at 30 minutes, 4 hours, and 24 hours&#xD;
      after surgery. Also, nausea and vomiting, time to ambulation, will be documented. After the&#xD;
      patients are discharged, their charts are going to be reviewed and their medical expenses&#xD;
      will be documented.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Functional hospital stay</measure>
    <time_frame>from end of surgery, until all discharge criteria had been met (an average of 3 days)</time_frame>
    <description>time from the end of surgery until all discharge criteria had been met</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain score</measure>
    <time_frame>30 minutes, 4 hours, and 24 hours after end of surgery</time_frame>
    <description>100 mm scale of visual analogue scale (0~100mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue drug and dosage</measure>
    <time_frame>30 minutes, 4 hours, and 24 hours after end of surgery</time_frame>
    <description>Rescue drug and dosage for additional analgesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting</measure>
    <time_frame>until patient discharge (an average of 3 days)</time_frame>
    <description>The presence or absence of postoperative nausea and vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to ambulation</measure>
    <time_frame>Time to ambulation (an average of 1 day)</time_frame>
    <description>Time to ambulation after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical expenses</measure>
    <time_frame>until patient discharge (an average of 4 days)</time_frame>
    <description>Medical expenses during inpatient (Korean won)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">54</enrollment>
  <condition>ERAS</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>E (ERAS protocol)</arm_group_label>
    <description>receive ERAS protocol 8 hours of fasting and ingestion of oral carbohydrate 2 hour before surgery TIVA(Total intra-venous anesthesia) TAP(transversus abdominis plane) block IV-PCA using NSAIDs after surgery Resuming oral intake 2 hours after surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C (Control)</arm_group_label>
    <description>receive standard perioperative care 8 hours of fasting before surgery Inhalation anesthesia IV-PCA using NSAIDs Resuming oral intake 6 hours after surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS protocol</intervention_name>
    <description>E: ERAS protocol C: control</description>
    <arm_group_label>E (ERAS protocol)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Morbidly obese patients undergoing elective laparoscopic bariatric surgery at Seoul&#xD;
        National Bundang Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists grade 1 ~ 3&#xD;
&#xD;
          -  BMI(Body Mass Index) â‰¥30&#xD;
&#xD;
          -  Scheduled for elective laparoscopic bariatric surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists grade 4 or 5&#xD;
&#xD;
          -  History of abdominal surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bon Wook Koo, MD</last_name>
    <role>Study Director</role>
    <affiliation>SNUBH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hun-Taek Lee, MD</last_name>
    <phone>82-10-6862-2864</phone>
    <email>htlee0@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bon Wook Koo, MD</last_name>
    <phone>82-31-787-7504</phone>
    <email>tendong2@gmail.com</email>
  </overall_contact_backup>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 23, 2021</study_first_submitted>
  <study_first_submitted_qc>May 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>May 26, 2021</last_update_submitted>
  <last_update_submitted_qc>May 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>BON WOOK KOO</investigator_full_name>
    <investigator_title>assistnat professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

